QQ客服 官方微博 反馈留言

	Dipeptidyl Peptidase-4 Inhibitor Use is Associated with Decreased Risk of Fracture in Patients with Type 2 Diabetes: A Population-Based Cohort Study.
	Hou Wen-Hsuan; Chang Kai-Cheng; Li Chung-Yi; Ou Huang-Tz
刊名	British journal of clinical pharmacology
	2018
关键词	CD26 antigen *DIABETICS *NON-insulin-dependent diabetes diagnosis *METFORMIN *DRUG efficacy
ISSN号	0306-5251;1365-2125
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5461962
专题	湖南大学
作者单位	http://orcid.org/0000-0002-4376-6298 School of Gerontology Health Management and Master Program in Long-Term Care, College of Nursing, Taipei Medical University, Taipei City, Taiwan. Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan. Department of Physical Medicine and Rehabilitation, Taipei Medical University Hospital, Taipei City, Taiwan. Center of Evidence-Based Medicine, Taipei Medical University, Taipei City, Taiwan. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan City, Taiwan. Department of Pharmacy, Chang Gung Memorial Hospital-Linkou, Taoyuan City, Taiwan. Department and Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan City, Taiwan. Department of Public Health, College of Public Health, China Medical University, Taichung City, Taiwan. http://orcid.org/0000-0002-5475-7848 Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
推荐引用方式 GB/T 7714	Hou Wen-Hsuan,Chang Kai-Cheng,Li Chung-Yi,et al. Dipeptidyl Peptidase-4 Inhibitor Use is Associated with Decreased Risk of Fracture in Patients with Type 2 Diabetes: A Population-Based Cohort Study.[J]. British journal of clinical pharmacology,2018.
APA	Hou Wen-Hsuan,Chang Kai-Cheng,Li Chung-Yi,&Ou Huang-Tz.(2018).Dipeptidyl Peptidase-4 Inhibitor Use is Associated with Decreased Risk of Fracture in Patients with Type 2 Diabetes: A Population-Based Cohort Study..British journal of clinical pharmacology.
MLA	Hou Wen-Hsuan,et al."Dipeptidyl Peptidase-4 Inhibitor Use is Associated with Decreased Risk of Fracture in Patients with Type 2 Diabetes: A Population-Based Cohort Study.".British journal of clinical pharmacology (2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。